Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Effect of intravenous tropisetron on modulation of pain and central hypersensitivity in chronic low back pain patients.

Neziri AY, Dickenmann M, Scaramozzino P, Andersen OK, Arendt-Nielsen L, Dickenson AH, Curatolo M.

Pain. 2012 Feb;153(2):311-8. doi: 10.1016/j.pain.2011.10.008. Epub 2011 Nov 17.

PMID:
22100357
2.

One failed clinical trial (of 5HT3 antagonists) does not invalidate the concept.

Förster M, Baron R.

Pain. 2012 Feb;153(2):263-4. doi: 10.1016/j.pain.2011.11.015. Epub 2011 Dec 9. No abstract available.

PMID:
22154218
3.

Spinal 5-HT3 receptor mediates nociceptive effect on central neuropathic pain; possible therapeutic role for tropisetron.

Nasirinezhad F, Hosseini M, Karami Z, Yousefifard M, Janzadeh A.

J Spinal Cord Med. 2016;39(2):212-9. doi: 10.1179/2045772315Y.0000000047. Epub 2015 Sep 4.

4.

The effect of paracetamol and tropisetron on pain: experimental studies and a review of published data.

Tiippana E, Hamunen K, Kontinen V, Kalso E.

Basic Clin Pharmacol Toxicol. 2013 Feb;112(2):124-31. doi: 10.1111/j.1742-7843.2012.00935.x. Epub 2012 Oct 20. Review.

5.
6.

Intravenous nonopioid analgesic drugs in chronic low back pain patients on chronic opioid treatment: a crossover, randomised, double-blinded, placebo-controlled study.

Wetzel L, Zadrazil M, Paternostro-Sluga T, Authried G, Kozek-Langenecker S, Scharbert G.

Eur J Anaesthesiol. 2014 Jan;31(1):35-40. doi: 10.1097/EJA.0b013e328365ae28. Retraction in: Eur J Anaesthesiol. 2015 Apr;32(4):287.

PMID:
24141646
7.

Tropisetron blocks analgesic action of acetaminophen: a human pain model study.

Bandschapp O, Filitz J, Urwyler A, Koppert W, Ruppen W.

Pain. 2011 Jun;152(6):1304-10. doi: 10.1016/j.pain.2011.02.003. Epub 2011 Mar 21.

PMID:
21420788
8.

Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia.

Späth M, Stratz T, Neeck G, Kötter I, Hammel B, Amberger CC, Haus U, Färber L, Pongratz D, Müller W.

Scand J Rheumatol. 2004;33(4):267-70.

PMID:
15370724
9.

Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism.

Pickering G, Loriot MA, Libert F, Eschalier A, Beaune P, Dubray C.

Clin Pharmacol Ther. 2006 Apr;79(4):371-8.

PMID:
16580905
10.

Treatment of chronic low back pain with tropisetron.

Stratz T, Müller W.

Scand J Rheumatol Suppl. 2004;119:76-8.

PMID:
15515421
11.

Fibromyalgia treatment with intravenous tropisetron administration.

Stratz T, Färber L, Varga B, Baumgartner C, Haus U, Müller W.

Drugs Exp Clin Res. 2001;27(3):113-8.

PMID:
11447769
12.

Efficacy and tolerability of tropisetron in primary fibromyalgia--a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group.

Färber L, Stratz T, Brückle W, Späth M, Pongratz D, Lautenschläger J, Kötter I, Zöller B, Peter HH, Neeck G, Alten R, Müller W.

Scand J Rheumatol Suppl. 2000;113:49-54.

PMID:
11028832
13.

A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia.

Vergne-Salle P, Dufauret-Lombard C, Bonnet C, Simon A, Trèves R, Bonnabau H, Bertin P.

Eur J Pain. 2011 May;15(5):509-14. doi: 10.1016/j.ejpain.2010.09.013. Epub 2010 Oct 30.

PMID:
21036635
15.

Tropisetron alleviate early post-operative pain after gynecological laparoscopy in sevoflurane based general anaesthesia: a randomized, parallel-group, factorial study.

Mei W, Li M, Yu Y, Cheung CW, Cao F, Nie B, Zhang Z, Wang P, Tian Y.

Eur J Pain. 2014 Feb;18(2):238-48. doi: 10.1002/j.1532-2149.2013.00365.x. Epub 2013 Jul 19.

PMID:
23868810
16.

Linking altered central pain processing and genetic polymorphism to drug efficacy in chronic low back pain.

Siegenthaler A, Schliessbach J, Vuilleumier PH, Juni P, Zeilhofer HU, Arendt-Nielsen L, Curatolo M.

BMC Pharmacol Toxicol. 2015 Sep 16;16:23. doi: 10.1186/s40360-015-0023-z.

17.

A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment.

Rauck RL, Hale ME, Bass A, Bramson C, Pixton G, Wilson JG, Setnik B, Meisner P, Sommerville KW, Malhotra BK, Wolfram G.

Pain. 2015 Sep;156(9):1660-9. doi: 10.1097/j.pain.0000000000000230.

PMID:
25993547
18.

Non-steroidal anti-inflammatory drugs for chronic low back pain.

Enthoven WT, Roelofs PD, Deyo RA, van Tulder MW, Koes BW.

Cochrane Database Syst Rev. 2016 Feb 10;2:CD012087. doi: 10.1002/14651858.CD012087. Review.

PMID:
26863524
19.

Managing chronic whiplash associated pain with a combination of low-dose opioid (remifentanil) and NMDA-antagonist (ketamine).

Lemming D, Sörensen J, Graven-Nielsen T, Lauber R, Arendt-Nielsen L, Gerdle B.

Eur J Pain. 2007 Oct;11(7):719-32. Epub 2007 Jan 2.

PMID:
17197214

Supplemental Content

Support Center